Single-center, prospective, placebo controlled trial of tolerability and safety of
low-concentration SinuSurf sinus irrigation solution in normal subjects. Forty (40) healthy
subjects aged 18-65 will be enrolled in the study.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center